7th Asia-Pacific Osteoporosis Conference: a successful forum for regional research and scientific exchange

IOF President Cyrus Cooper speaking at opening ceremony
Congress Chairs, Dr Manju Chandran and Prof. John Kanis
Scientific Committee Co-chair Prof. Serge Ferrari
IOF conference highlighted new research and clinical advances in the prevention, diagnosis and management of osteoporosis as well as key topics in osteoarthritis, osteosarcopenia and orthopaedic surgery.

Leading musculoskeletal disease researchers and some 650 health professionals from 69 countries attended the IOF Regional 7th Asia-Pacific Osteoporosis Conference, a CME-accredited IOF event held in Sydney, Australia from November 29 to December 1, 2018.

Forecasts for Asia, with its rapidly ageing and growing populations, indicate that by 2050 the region will be faced with 50% of the world’s hip fractures. The new research findings and clinical advances presented at the IOF Regional Conference gave delegates valuable new insights to help tackle this health crisis through improved patient care and the targeted prevention of secondary fragility fractures in the high-risk population. In addition, it helped to increase our understanding of the similarities and differences in fracture risk and treatment response between Asia and the West,”

stated IOF CEO Philippe Halbout. He added,

We were delighted to present 272 research abstracts - the highest number accepted for an IOF regional conference to date. Indeed, the high quality of the abstracts prompted the Scientific Committee to increase the number of oral presentations within the program. This development reflects the excellent research being carried out in the Asia-Pacific region.”

The Conference was organized by IOF under the leadership of Conference Chairs, Professor John Kanis (UK) and Dr Manju Chandran (Singapore), and by Scientific Committee Chairs Professor Serge Ferrari (Switzerland) and Professor Joon Kiong Lee (Malaysia). Its wide ranging scientific programme presented new advances in the prevention, diagnosis and treatment of osteoporosis and related fragility fractures in seven Plenary Sessions, 11 Meet-the-Expert Sessions, ten oral presentations, three special sessions, three joint symposia, and three industry-sponsored symposia. Specific sessions focused on IOF’s Global Map of Dietary Calcium Intake, knee osteoarthritis, osteosarcopenia, falls prevention, and orthopaedic surgery, addressed other important topics related to bone, muscle and joint health.

For a complete overview of the program and to download the abstracts, click here.

View the following interviews discussing the Conference: 

Prior to the opening, on November 28 and 29, the popular IOF-ISCD training course ‘Osteoporosis: Essentials of Densitometry,Diagnosis and Management’ took place. The course, available for local organizers worldwide, was attended by some 130 clinicians and technologists who eagerly participated in this opportunity to gain practical knowledge and skills for their clinical practice.

The growing importance of global cooperation in the musculoskeletal field was reflected in the three joint symposia held at the conference - with Osteoporosis Australia (OA), the Australian & New Zealand Bone and Mineral Society (ANZBMS), and the Asia Pacific Orthopedic Association (APOA). This spirit of collaboration was also highlighted in the launch of two important new regional alliances. The Asia-Pacific Fragility Fracture Alliance, a new multidisciplinary alliance to curb Asia Pacific’s fragility fracture epidemic, was launched on November 29th prior to the start of the Conference. As well, on November 30th, IOF and the Asian Federation of Osteoporosis Societies (AFOS) and the International Society for Clinical Densitometry (ISCD) came together to launch the IOF-ISCD-AFOS Regional Alliance, which will provide a common platform to enhance and support the organizations’ endeavours in the region.

Another special feature of the Meeting was the presentation of the IOF-Agnovos Young Investigator Awards to six researchers under the age of 40 who submitted outstanding abstracts to the meeting. The winners, who received official recognition during a dedicated session on December 1st, are D. Alarkawi, K. Holloway-Kew, H. Nguyen, F. Pan, D. Scott, and Y. Yang.

IOF thanks the speakers and delegates whose enthusiastic participation helped make the Conference such a great success. We also gratefully acknowledge the unrestricted support received from Amgen (Platinum), Lilly (Silver) and supporters Medtronic, Medi, Pfizer Consumer Healthcare, and AgNovos Healthcare.